Quantcast
Home > Quotes > GMED

Globus Medical, Inc. Class A Common Stock (GMED) Quote & Summary Data

GMED 
$47.48
*  
0.80
1.71%
Get GMED Alerts
*Delayed - data as of Mar. 18, 2019  -  Find a broker to begin trading GMED now
Exchange:NYSE
Industry: Health Care
Community Rating:
View:    GMED Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

1 Year Target
58
Today's High / Low
$ 47.52 / $ 46.58
Share Volume
784,030
90 Day Avg. Daily Volume
724,179
Previous Close
$ 46.68
52 Week High / Low
$ 57.83 / $ 38.01
Market Cap
4,684,065,806
P/E Ratio
30.83
Forward P/E (1y)
27.14
Earnings Per Share (EPS)
$ 1.54
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.99

Intraday Chart

Shares Traded

Share Volume:
784,030
90 Day Avg. Daily Volume:
724,179

P/E Ratio

P/E Ratio:
30.83
Forward P/E (1y):
27.14
Earnings Per Share (EPS):
$ 1.54

Trading Range

The current last sale of $47.48 is 24.91% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 47.52 $ 57.83
 Low: $ 46.58 $ 38.01

ETFs with GMED as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
1.86% Invesco S&P Midcap 400 Pure Growth ETF (RFG) -0.75 (-0.50%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Globus Medical, Inc. (together, as applicable, with its consolidated subsidiaries, "Globus," "we," "us" or "our"), headquartered in Audubon, Pennsylvania, is a medical device company that develops and commercializes healthcare solutions whose mission is to improve the quality of life of patients with musculoskeletal disorders. Founded in 2003, Globus is committed to medical device innovation and delivering exceptional service to hospitals and physicians to advance patient care and improve efficiency. Since inception, Globus has listened to the voice of the surgeon to develop practical solutions and products to help surgeons effectively treat patients and improve lives. We have expanded our sales operations across the globe and now serve customers in 52 countries worldwide. Globus is an engineering-driven company with a history of rapidly developing and commercializing advanced products and procedures to address treatment challenges.  ... More ...  



Risk Grade

Where does GMED fit in the risk graph?


Risk Grade Scale



Consensus Recommendation

Analyst Info